DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Elon Musk - 1 Daron Acemoglu - 1 Goldman Sachs - 1 Eli Lilly Eli Lilly - 1 Eli Lilly - 1 Biogen's Leqembi - 1
Top related locs:
U.S
Top related orgs:
CNBC Pro - 1 Nvidia - 1 CNBC - 1 Stock - 1 Artificial Intelligence - 1 Broadcom - 1 Lam Research - 1 Intel - 1

Search resuls for: "Biogen's Leqembi"


2 mentions found


☆ These are the most expensive S&P 500 stocks heading into the second half
  + stars: | 2024-06-27 | by ( Brian Evans | ) www.cnbc.com   time to read: +4 min
Artificial Intelligence plays Top AI plays were among the list of expensive stocks in the S & P 500, including Broadcom , Lam Research , Intel and Super Micro Computer . Each stock's price-earnings ratio equates to a roughly 60% to 66% premium over the historical average. SMCI YTD mountain Super Micro Computer stock. Super Micro Computer, meanwhile, has continued to ride the AI wave despite some weakness last month after third-quarter revenue missed analyst expectations. The stock's trailing 12-month price-earnings ratio is also more than double its five-year average, at a 63% premium.
Persons: Elon Musk, Daron Acemoglu, Goldman Sachs, Eli Lilly Eli Lilly, Eli Lilly, Biogen's Leqembi Organizations: CNBC Pro, Nvidia, CNBC, Stock, Artificial Intelligence, Broadcom, Lam Research, Intel, Micro, Super Micro Computer, Computer, Wall, Bank of America, Micro Computer, Dell, Massachusetts Institute of Technology, U.S . Food, Drug Administration Locations: U.S
☆ 'It totally backfired': The pitfalls of Alzheimer's genetic testing
  + stars: | 2023-04-21 | by ( Julie Steenhuysen | ) www.reuters.com   time to read: +8 min
CHICAGO, April 21 (Reuters) - Wendy Nelson watched her mother slowly die of Alzheimer's disease, unable to move or swallow at the end. When her father's memory began to fail a year later, one of her two sisters doubted it could be Alzheimer's, Nelson said. THE TESTING REVOLUTIONUntil recently, most doctors tended not to order genetic tests to determine Alzheimer's risk, because there were no effective treatments to slow or prevent the disease. US regulators recommend genetic testing before starting treatment with Leqembi. Some members of families with increased genetic risk of Alzheimer's say it might be better not to know at all.
0 next >>
Total: 2